Can we check serum lithium levels less often without compromising patient safety?. Issue 1 (17th January 2022)

• Record Type: Journal Article
• Authors: Heald, Adrian H.; Holland, David; Stedman, Michael; Davies, Mark; Duff, Chris J.; Parfitt, Ceri; Green, Lewis; Scargill, Jonathan; Taylor, David; Fryer, Anthony A.
• Is Part Of: BJPsych open. Volume 8:Issue 1(2022)
• Publication Date: 2022-01-17
• Subjects: Lithium -- level -- testing -- interval -- safety; Psychiatry -- Periodicals; Mental health -- Periodicals; 616.89005
• DOI: 10.1192/bjo.2021.1027
• Languages: English
• ISSNs: 2056-4724

Abstract

Abstract : Background: Lithium is viewed as the first-line long-term treatment for prevention of relapse in people with bipolar disorder. Aims: This study examined factors associated with the likelihood of maintaining serum lithium levels within the recommended range and explored whether the monitoring interval could be extended in some cases. Method: We included 46 555 lithium rest requests in 3371 individuals over 7 years from three UK centres. Using lithium results in four categories (<0.4 mmol/L; 0.40–0.79 mmol/L; 0.80–0.99 mmol/L; ≥1.0 mmol/L), we determined the proportion of instances where lithium results remained stable or switched category on subsequent testing, considering the effects of age, duration of lithium therapy and testing history. Results: For tests within the recommended range (0.40–0.99 mmol/L categories), 84.5% of subsequent tests remained within this range. Overall, 3 monthly testing was associated with 90% of lithium results remaining within range, compared with 85% at 6 monthly intervals. In cases where the lithium level in the previous 12 months was on target (0.40–0.79 mmol/L; British National Formulary/National Institute for Health and Care Excellence criteria), 90% remained within the target range at 6 months. Neither age nor duration of lithium therapy had any significant effect on lithium level stability. Levels within the 0.80–0.99 mmol/L category were linked to a higher probability of moving to the ≥1.0 mmol/L category (10%) compared with those in the 0.4–0.79 mmol/L group (2%), irrespective of testing frequency. Conclusion: We propose that for those who achieve 12 months of lithium tests within the 0.40–0.79 mmol/L range, the interval between tests could increase to 6 months, irrespective of age. Where lithium levels are 0.80–0.99 mmol/L, the test interval should remain at 3 months. This could reduce lithium test numbers by 15% and costs by ~$0.4 m p.a.